Literature DB >> 12532374

Effect of flavonoids on MRP1-mediated transport in Panc-1 cells.

Hang Nguyen1, Shuzhong Zhang, Marilyn E Morris.   

Abstract

The purpose of this study was to identify the effects of dietary flavonoids, which are present in fruits, vegetables, and plant-derived beverages, on the transport of daunomycin (DNM) and vinblastine (VBL) in Panc-1 cells. Panc-1 is a human pancreatic adenocarcinoma cell line, which expresses Multidrug Resistance-Associated Protein1 (MRP1). The 2-h accumulation of (3)H-DNM and (3)H-VBL was determined in the presence and absence of 22 flavonoids. Biochanin-A, genistein, quercetin, chalcone, silymarin, phloretin, morin, and kaempferol, at 100 microM concentrations, all significantly increased the accumulation of both DNM and VBL in Panc-1 cells, with morin increasing DNM and VBL accumulation by 546 +/- 50% (mean +/- SE, n = 9) and 553 +/- 37% (n = 9), respectively. Fisetin treatment significantly decreased the accumulation of both DNM and VBL. Concentration-dependent studies demonstrated significant effects on VBL accumulation at 50 microM, but not at 10 microM concentrations, except for chalcone that was effective at a 10 microM concentration. Following a 24-h incubation, there were no changes in MRP1 membrane expression or glutathione-S-transferase activity in cells. Cellular glutathione (GSH) concentrations were significantly decreased following a 2-h incubation with biochanin A, chalcone, genistein, phloretin, quercetin, and silymarin, and following a 24-h incubation with biochanin A, chalcone, genistein, and phloretin. These results therefore indicate that the flavonoids morin, chalcone, silymarin, phloretin, genistein, quercetin, biochanin A, and kaempferol can inhibit MRP1-mediated drug transport, effects that may involve binding interactions with MRP1, as well as modulation of GSH concentrations. Copyright 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 92:250-257, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532374     DOI: 10.1002/jps.10283

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  25 in total

Review 1.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

3.  The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-beta-D-xylopyranosyl-(1-6) -beta-D-glucopyranoside in the human intestinal cell line caco-2.

Authors:  Xiaojuan Tian; Xiaoda Yang; Kui Wang; Xiuwei Yang
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Flavonoid-induced glutathione depletion: potential implications for cancer treatment.

Authors:  Remy Kachadourian; Brian J Day
Journal:  Free Radic Biol Med       Date:  2006-03-31       Impact factor: 7.376

Review 5.  Pancreatic cancer stem cells: fact or fiction?

Authors:  Vikash J Bhagwandin; Jerry W Shay
Journal:  Biochim Biophys Acta       Date:  2009-02-21

6.  Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2).

Authors:  Sonia R Miranda; Jin Kyung Lee; Kim L R Brouwer; Zhiming Wen; Philip C Smith; Roy L Hawke
Journal:  Drug Metab Dispos       Date:  2008-08-07       Impact factor: 3.922

7.  Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers.

Authors:  Yang Han; Dong Guo; Yao Chen; Yu Chen; Zhi-Rong Tan; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2009-02-17       Impact factor: 2.953

8.  Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats.

Authors:  K Kishore Kumar; Leena Priyanka; K Gnananath; P Ravindra Babu; S Sujatha
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-05-29       Impact factor: 2.441

Review 9.  Fisetin: a dietary antioxidant for health promotion.

Authors:  Naghma Khan; Deeba N Syed; Nihal Ahmad; Hasan Mukhtar
Journal:  Antioxid Redox Signal       Date:  2012-12-18       Impact factor: 8.401

10.  Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein.

Authors:  Stephen W J Wang; Yan Chen; Tiby Joseph; Ming Hu
Journal:  J Altern Complement Med       Date:  2008-04       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.